Catalyst Wire Dossier Catalyst Wire Dossier

Merimepodib (MMPD)

Merimepodib · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Merimepodib (MMPD), covering 2007-12-21 to 2007-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C [Phase 2]

See pricing